2012
DOI: 10.1186/1753-6561-6-s4-o44
|View full text |Cite
|
Sign up to set email alerts
|

Renal quality outcomes framework and eGFR: impact on secondary care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 25 publications
0
9
0
Order By: Relevance
“…202 A second set of studies assessed the impact of the QOF on hospital utilisation. [199][200][201]203 This pay-for-performance scheme did not (initially) have any incentives related to outpatient referrals but did provide incentives for chronic disease management that could have impacted on referrals. The evidence is clear that it did, with a step increase in referrals to renal clinics after the introduction of an incentive to identify and manage patients with renal failure, 199,201 and an increase in referrals to a diabetic clinic when tighter targets for blood sugar control were introduced into the QOF.…”
Section: Scoping Review (Main Study)mentioning
confidence: 99%
See 1 more Smart Citation
“…202 A second set of studies assessed the impact of the QOF on hospital utilisation. [199][200][201]203 This pay-for-performance scheme did not (initially) have any incentives related to outpatient referrals but did provide incentives for chronic disease management that could have impacted on referrals. The evidence is clear that it did, with a step increase in referrals to renal clinics after the introduction of an incentive to identify and manage patients with renal failure, 199,201 and an increase in referrals to a diabetic clinic when tighter targets for blood sugar control were introduced into the QOF.…”
Section: Scoping Review (Main Study)mentioning
confidence: 99%
“…[199][200][201]203 This pay-for-performance scheme did not (initially) have any incentives related to outpatient referrals but did provide incentives for chronic disease management that could have impacted on referrals. The evidence is clear that it did, with a step increase in referrals to renal clinics after the introduction of an incentive to identify and manage patients with renal failure, 199,201 and an increase in referrals to a diabetic clinic when tighter targets for blood sugar control were introduced into the QOF. 203 Referrals also increased to neurology clinics following an incentive to provide better seizure control for patients with epilepsy, 200 although in this study a neurologist provided additional educational support to practices at the same time.…”
Section: Scoping Review (Main Study)mentioning
confidence: 99%
“…1,3,4 At present, there is evidence that a large proportion of people with CKD are undiagnosed and that management is suboptimal, with evidence to suggest that practitioners do not currently readily accept national guidelines. [5][6][7] A range of concerns have been raised by GPs, including difficulties associated with: assigning a diagnosis; the stigmatising effect of a diagnosis; explaining the concept of CKD to patients; achieving blood pressure targets; complicated medication regimens; and uncertainty about referral to secondary care. 8 The introduction of guidelines for the management of CKD requires a considerable change in behaviour by primary care clinicians.…”
Section: Introductionmentioning
confidence: 99%
“…Reports have shown an increase of 3-6 years in the mean age of the referral population to nephrologists post-eGFR reporting. 1,23,24 Concurrently, there have been increases of 6%-25% in women detected and referred to nephrology care with eGFR reporting. 2,23 With advanced CKD, ongoing sarcopenia, malnutrition, and higher comorbidity have led to this same population being initiated on dialysis at higher levels of eGFR.…”
Section: Discussionmentioning
confidence: 99%